To determine how much insulin-dependent diabetes increases a woman's risk of giving birth to a malformed infant and how that risk is influenced by metabolic control, we followed 347 diabetic and 389 control women who enrolled in the study within 21 days of conception (the early-entry group) and 279 diabetic women who entered later (the late-entry group). We detected major malformations in the infants of 4.9 percent of the early-entry diabetic women, 2.1 percent of the controls, and 9.0 percent of the late-entry diabetic women. Malformation rates were significantly higher among offspring of early-entry diabetic women than among those of controls (odds ratio, 2.45; lower one-sided 95 percent confidence limit, 1.12; P = 0.027), and higher among late-entry than among early-entry diabetic women (odds ratio, 1.91; lower one-sided 95 percent confidence limit, 1.07; P = 0.032). Mean blood glucose and glycosylated hemoglobin levels during organogenesis were not significantly higher in women whose infants were malformed. Hypoglycemia (glucose, less than or equal to 50 mg per deciliter [2.8 mmol per liter]) was not significantly more common in the same group. Hyperglycemia and glycosylated hemoglobin were not correlated with malformation. The data suggest that more sensitive measures are needed to identify the teratogenic mechanisms, or that not all malformation can be prevented by good glycemic control. Despite the increased malformation rate among infants of the early-entry diabetic women, as compared with the controls, the more favorable outcome seen in the former group as compared with the late-entry group justifies the attempt to achieve good metabolic control around the time of conception.
Source Information
Epidemiology Branch, National Institute of Child Health and Human Development, Bethesda, Md 20892.
This article has been cited by other articles:
Charron-Prochownik, D., Ferons-Hannan, M., Sereika, S., Becker, D.
(2008). Randomized Efficacy Trial of Early Preconception Counseling for Diabetic Teens (READY-Girls). Diabetes Care
31: 1327-1330
[Abstract][Full Text]
Fraser, R.B., Waite, S.L., Wood, K.A., Martin, K.L.
(2007). Impact of hyperglycemia on early embryo development and embryopathy: in vitro experiments using a mouse model. Hum Reprod
22: 3059-3068
[Abstract][Full Text]
Murphy, H. R, Temple, R. C, Roland, J. M
(2007). Improving outcomes of pregnancy for women with type 1 and type 2 diabetes. British Journal of Diabetes & Vascular Disease
7: 38-42
[Abstract]
Jovanovic, L., Knopp, R. H., Kim, H., Cefalu, W. T., Zhu, X.-D., Lee, Y. J., Simpson, J. L., Mills, J. L., for the Diabetes in Early Pregnancy Study Group,
(2005). Elevated Pregnancy Losses at High and Low Extremes of Maternal Glucose in Early Normal and Diabetic Pregnancy: Evidence for a protective adaptation in diabetes. Diabetes Care
28: 1113-1117
[Abstract][Full Text]
Shaw, G. M, Quach, T., Nelson, V., Carmichael, S. L, Schaffer, D. M, Selvin, S., Yang, W.
(2003). Neural tube defects associated with maternal periconceptional dietary intake of simple sugars and glycemic index. Am. J. Clin. Nutr.
78: 972-978
[Abstract][Full Text]
Wren, C, Birrell, G, Hawthorne, G
(2003). Cardiovascular malformations in infants of diabetic mothers. Heart
89: 1217-1220
[Abstract][Full Text]
Bloomgarden, Z. T.
(2002). Neuropathy, Womens' Health, and Socioeconomic Aspects of Diabetes. Diabetes Care
25: 1085-1094
[Full Text]
Ray, J.G., O'brien, T.E., Chan, W.S.
(2001). Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis. QJM
94: 435-444
[Abstract][Full Text]
Jovanovic, L.
(2001). What Is So Bad About a Big Baby?. Diabetes Care
24: 1317-1318
[Full Text]
Dorman, J. S., Steenkiste, A. R., Foley, T. P., Strotmeyer, E. S., Burke, J. P., Kuller, L. H., Kwoh, C. K.
(2001). Menopause in Type 1 Diabetic Women: Is it Premature?. Diabetes
50: 1857-1862
[Abstract][Full Text]
Jovanovic, L., Knopp, R. H., Brown, Z., Conley, M. R., Park, E., Mills, J. L., Metzger, B. E., Aarons, J. H., Holmes, L. B., Simpson, J. L.
(2001). Declining Insulin Requirement in the Late First Trimester of Diabetic Pregnancy. Diabetes Care
24: 1130-1136
[Abstract][Full Text]
Ornoy, A, Wolf, A, Ratzon, N, Greenbaum, C, Dulitzky, M
(1999). Neurodevelopmental outcome at early school age of children born to mothers with gestational diabetes. Arch. Dis. Child. Fetal Neonatal Ed.
81: 10F-14
[Abstract][Full Text]
Ornoy, A, Ratzon, N, Greenbaum, C, Peretz, E, Soriano, D, Dulitzky, M
(1998). Neurobehaviour of school age children born to diabetic mothers. Arch. Dis. Child. Fetal Neonatal Ed.
79: 94F-99
[Abstract][Full Text]
Reece, E. A., Homko, C. J., Wu, Y.-K., Wiznitzer, A.
(1998). The Role of Free Radicals and Membrane Lipids in Diabetes-Induced Congenital Malformations. Reproductive Sciences
5: 178-187
[Abstract]
Casele, H. L., Laifer, S. A.
(1998). Factors Influencing Preconception Control of Glycemia in Diabetic Women. Arch Intern Med
158: 1321-1324
[Abstract][Full Text]
Betschart, J.
(1996). Oral Contraception and Adolescent Women With Insulin-Dependent Diabetes Mellitus: Risks, Benefits, and Implications for Practice. The Diabetes Educator
22: 374-378
Matheson, D., Efantis, J.
(1989). Diabetes and Pregnancy: Need and Use of Intensive Therapy. The Diabetes Educator
15: 242-248
(1988). MALFORMATION RATES IN INFANTS OF DIABETIC MOTHERS. JWatch General
1988: 2-2
[Full Text]
Previous
